Are you taking erectile dysfunction seriously enough?

Survey reveals surprising results



This content is produced by Australian Doctor Group in partnership with Eli Lilly Australia.


To start a conversation with your patients, download the Lilly Men’s Health screening tool

Visit Lilly Men’s Health to learn more:


PBS Information. This product is not available on the PBS


Please review the full product information (PI) before prescribing,
Full PI is available from

Approved Indication: Erectile dysfunction (ED) and moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult males.
Dosage and Administration: ED On-Demand Dosing -10mg or 20mg prior to anticipated sexual activity. Max. 20mg per day. Effective up to 36 hours after dosing and in some patients as early as 16 minutes after dosing. ED and/or LUTS/BPH Once-A-Day Dosing - 5mg once daily, approximately the same time every day. Dose must not exceed 5mg daily. Contraindications: Concomitant use with Nitrates, hypersensitivity to tadalafil or its excipients, unstable cardiovascular disease, myocardial infarction within the last 90 days, unstable angina or angina, New York Heart Association Class 2 or greater heart failure in the last 6 months, uncontrolled arrhythmias, severe or uncontrolled hypertension, stroke within the last 6 months, loss of vision in one eye due to non-arteritic anterior ischaemic optic neuropathy (NAION), *the combination use with guanylate cyclase stimulators may lead to symptomatic hypotension. Precautions: Medical assessment prior to treatment, LUTS/BPH patients rule out prostate cancer and assess cardiovascular conditions, severe renal impairment (CrCl ≤50mL/min), severe hepatic insufficiency, risk in patients with pre-existing cardiovascular disease, patients predisposed to priapism. potential risk of hypotensive events ≥ 75 years, sudden loss of vision or decrease/loss of hearing. Interactions: anti-hypertensives, other erectile dysfunction treatments, non-selective alpha[1] blockers, CYP3A4 or HIV protease inhibitors, *Riociguat. Adverse Effects: Very Common (≥ 10%): dyspepsia, headache. Common (≥ 1% and < 10%): nausea, vomiting, fatigue, flushing, back pain, myalgia, pain in extremity, nasal congestion, gastroesophageal reflux disease, diarrhoea, abdominal pain, upper respiratory tract infection, hypertension. Refer to full PI for a complete list. Please review full PI before prescribing which is available on request from Eli Lilly Australia Pty. Limited. 112 Wharf Road, West Ryde NSW 2114.  Based on PI last amended 27 October 2017.

*Please note changes in the Product Information.

CIALIS® is a registered trademark of Eli Lilly and Company. Eli Lilly Australia Pty Limited. ABN 39 000233 992, Telephone: 02 9325 4444. 112 Wharf Road, West Ryde NSW 2114. PP-TD-AU-0024, December 2017.